The Europe anesthesia needles and syringes market size is anticipated to reach USD 388.81 million by 2030 and is projected to grow at a CAGR of 16.5% during the forecast period. The growing elderly population is anticipated to improve the demand for anesthetic needles and syringes. This is due to the higher prevalence of surgeries and medical procedures requiring anesthesia among older individuals. According to data published by the House of Commons in July 2024, around 19% of people in the UK were aged 65 or over in 2022, which is projected to rise to 27% by 2072.
The rising awareness among patients and stringent regulations around medical device safety and reimbursement policies encourage the adoption of advanced, safety-engineered needles and syringes, which enable market growth over the forecast period. The increasing need for regional anesthesia is expected to drive the demand for anesthesia syringes and needles in the coming decade. The use of regional anesthesia in surgeries is projected to rise substantially due to its various benefits compared to general anesthesia, such as lower cost, better environmental impact, and reduced incidence of vomiting & nausea. These benefits are anticipated to drive the demand for regional anesthesia.
The European healthcare infrastructure is rapidly growing with government investments and initiatives, which has boosted the market growth over the forecast period. For instance, according to the International Trade Administration, Denmark spends approximately 10% of its GDP on healthcare annually, amounting to over USD 7,000 per capita. Between 2019 and 2021, annual expenditures increased from USD 34 billion to USD 40 billion.
The rising awareness among patients and stringent regulations around medical device safety and reimbursement policies encourage the adoption of advanced, safety-engineered needles and syringes, which enable market growth over the forecast period. The increasing need for regional anesthesia is expected to drive the demand for anesthesia syringes and needles in the coming decade. The use of regional anesthesia in surgeries is projected to rise substantially due to its various benefits compared to general anesthesia, such as lower cost, better environmental impact, and reduced incidence of vomiting & nausea. These benefits are anticipated to drive the demand for regional anesthesia.
The European healthcare infrastructure is rapidly growing with government investments and initiatives, which has boosted the market growth over the forecast period. For instance, according to the International Trade Administration, Denmark spends approximately 10% of its GDP on healthcare annually, amounting to over USD 7,000 per capita. Between 2019 and 2021, annual expenditures increased from USD 34 billion to USD 40 billion.
Europe Anesthesia Needles and Syringes Market Report Highlights
- Anesthesia needles dominated the product segment, with a 64.22% share in 2023, owing to innovations such as enhanced needle designs that offer greater precision, reduced pain, and increased safety.
- The anesthesia syringes segment is expected to grow at the fastest CAGR over the forecast period.
- The traditional segment dominated the market with a 96.71% share in 2023, owing to the growing awareness about the complications associated with needlestick injuries. The NRFit segment is anticipated to witness the fastest growth over the forecast period.
- Hospitals dominated the end use segment with 46.08% share in 2023 owing to the high volume of surgical and diagnostic procedures performed in these settings.
- The ambulatory surgical segment is expected to grow at the fastest CAGR over the forecast period.
- The UK market is expected to grow over the forecast period owing to the expansion of healthcare infrastructure, including new hospitals and surgical centers, which will contribute to the higher demand for these essential devices.
The leading players in the Europe Anesthesia Needles and Syringes market include:
- BD (Becton, Dickinson & Corporation)
- B. Braun SE
- SolM
- GBUK Group Ltd.
- Vygon (UK) Ltd
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. Product Type Business Analysis
Chapter 5. Safety Features Business Analysis
Chapter 6. End Use Business Analysis
Chapter 7. Anesthesia Needles and Syringes Market: Regional Estimates & Trend Analysis by Product, Safety Features, End Use
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players in the Europe Anesthesia Needles and Syringes market include:- BD (Becton, Dickinson & Corporation)
- B. Braun SE
- SolM
- GBUK Group Ltd.
- Vygon (UK) Ltd
Methodology
LOADING...
